AlphaYouGH
Insider selling
Gwenn Hansen sold $109K of Nurix Therapeutics, Inc. (NRIX) stock
Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX), sold 4,356 shares of NRIX stock worth $109K, per an SEC Form 4 filed Aug 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Aug 5, 2026.
NRIX has moved +1.2% since the trade date, from $25.12 to $25.41 (Sep 21, 2026 close).
- Traded
- Aug 5, 2026
- Disclosed
- Aug 5, 2026
- Filing delay
- 0 days
- Price since
- +1.2%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More NRIX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.